4-((2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl)cyclohexanecarboxylic acid, 95.0%, 25g

4-Bromo-2,3-dimethylbenzoic acid, 95.0%, 1g

(3-((4-(tert-Butoxycarbonyl)piperazin-1-yl)methyl)phenyl)boronic acid, 98%, 250mg

(2,4-DIHYDROXY-5-ISOPROPYLPHENYL)(5-((4-METHYLPIPERAZIN-1-YL)METHYL)ISOINDOLIN-2-YL)METHANONE, 98%, 5mg

Reattori per la sintesi di peptidi, 20 ml, 100 pezzi, 100 pezzi

Ethyl 2-(3-oxocyclohexyl)benzoate, 97.0%, 1g

N-(2-aminoethyl)-N-methylmethanesulfonamide hydrochloride, 95.0%, 5g

1-Bromo-9H-fluoren-9-one, 98%, 100mg

2-BENZYL-6-NITRO-1,2,3,4-TETRAHYDROISOQUINOLINE, 95.0%, 250mg

(R)-5,5-Dimethyl-4-phenyloxazolidin-2-one, 95.0%, 100mg

(4-Bromo-2-methylphenyl)boronic acid, 95.0%, 5g

2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide, 95.0%, 5mg

2-Hydrazino-4-methyl-1,3-thiazole hydrochloride, 95.0%, 5g